What is Phaco?
Phaco, operating under the name Surgical Design, is at the forefront of developing innovative disposable phaco handpieces designed to integrate both phaco and I/A functionalities. Their advanced medical devices are engineered to elevate surgical performance in ophthalmic procedures, concurrently mitigating complications and reducing the financial burdens associated with conventional handpieces. The inherent disposability of Phaco's offerings significantly curtails infection risks and negates the necessity for autoclaving, thereby setting new benchmarks in ophthalmic surgery technology.
How much funding has Phaco raised?
Phaco has raised a total of $65K across 1 funding round:
Debt
$65K
Debt (2021): $65K with participation from PPP
Key Investors in Phaco
PPP
Public-Private Partnership
What's next for Phaco?
With the recent influx of substantial expansion capital, Phaco is poised for significant scaling and further innovation in the ophthalmic surgical device market. This strategic investment, indicative of a Series B/C stage, will likely fuel advancements in product development, market penetration, and operational expansion. The company's focus on disposable, integrated phaco handpieces addresses key industry needs for enhanced safety, efficiency, and cost-effectiveness, suggesting a strong potential for market leadership and continued growth.
See full Phaco company page
